MXPA03001085A - Farmaceutico novedoso. - Google Patents

Farmaceutico novedoso.

Info

Publication number
MXPA03001085A
MXPA03001085A MXPA03001085A MXPA03001085A MXPA03001085A MX PA03001085 A MXPA03001085 A MX PA03001085A MX PA03001085 A MXPA03001085 A MX PA03001085A MX PA03001085 A MXPA03001085 A MX PA03001085A MX PA03001085 A MXPA03001085 A MX PA03001085A
Authority
MX
Mexico
Prior art keywords
tartrate
solvate
compound
accordance
dione
Prior art date
Application number
MXPA03001085A
Other languages
English (en)
Spanish (es)
Inventor
Andrew Simon Craig
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of MXPA03001085A publication Critical patent/MXPA03001085A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/08—Antibacterial agents for leprosy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Diabetes (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Cosmetics (AREA)
  • Apparatus For Disinfection Or Sterilisation (AREA)
MXPA03001085A 2000-08-04 2001-08-03 Farmaceutico novedoso. MXPA03001085A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0019224.5A GB0019224D0 (en) 2000-08-04 2000-08-04 Novel pharmaceutical
PCT/GB2001/003511 WO2002012232A1 (en) 2000-08-04 2001-08-03 Tartrate salt of thiazolidinedione derivative

Publications (1)

Publication Number Publication Date
MXPA03001085A true MXPA03001085A (es) 2003-05-27

Family

ID=9897026

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA03001085A MXPA03001085A (es) 2000-08-04 2001-08-03 Farmaceutico novedoso.

Country Status (37)

Country Link
US (1) US20040014790A1 (ja)
EP (1) EP1305311B1 (ja)
JP (1) JP2004505970A (ja)
KR (1) KR100755174B1 (ja)
CN (1) CN1455778A (ja)
AP (1) AP1785A (ja)
AT (1) ATE384059T1 (ja)
AU (1) AU2001276506A1 (ja)
BG (1) BG107604A (ja)
BR (1) BR0112982A (ja)
CA (1) CA2417827A1 (ja)
CY (1) CY1107252T1 (ja)
CZ (1) CZ2003313A3 (ja)
DE (1) DE60132461T2 (ja)
DK (1) DK1305311T3 (ja)
DZ (1) DZ3418A1 (ja)
EA (1) EA005408B1 (ja)
EC (1) ECSP034467A (ja)
ES (1) ES2296772T3 (ja)
GB (1) GB0019224D0 (ja)
HK (1) HK1057358A1 (ja)
HR (1) HRP20030068B1 (ja)
HU (1) HUP0300778A3 (ja)
IL (2) IL154275A0 (ja)
MA (1) MA25832A1 (ja)
MX (1) MXPA03001085A (ja)
NO (1) NO324596B1 (ja)
NZ (1) NZ524030A (ja)
OA (1) OA12354A (ja)
PL (1) PL360662A1 (ja)
PT (1) PT1305311E (ja)
SI (1) SI1305311T1 (ja)
SK (1) SK1462003A3 (ja)
UA (1) UA76720C2 (ja)
WO (1) WO2002012232A1 (ja)
YU (1) YU14603A (ja)
ZA (1) ZA200300961B (ja)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE39384E1 (en) 1993-09-01 2006-11-07 Smithkline Beecham P.L.C. Substituted thiazolidinedione derivatives
DE102005034406A1 (de) * 2005-07-22 2007-02-01 Ratiopharm Gmbh Neue Salze von Rosiglitazon
US7435741B2 (en) * 2006-05-09 2008-10-14 Teva Pharmaceutical Industries, Ltd. 2-N{5-[[4-[2-(methyl-2-pyridinylamino) ethoxy] phenyl]methyl]-2,4-thiazolidinedione} butanedioic acid, methods of preparation and compositions with rosiglitazone maleate
US10828429B2 (en) 2015-10-27 2020-11-10 Nanopass Technologies Ltd. Microneedle device with mechanical guide

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9218830D0 (en) * 1992-09-05 1992-10-21 Smithkline Beecham Plc Novel compounds

Also Published As

Publication number Publication date
GB0019224D0 (en) 2000-09-27
PL360662A1 (en) 2004-09-20
HRP20030068B1 (en) 2008-07-31
AU2001276506A1 (en) 2002-02-18
EA200300230A1 (ru) 2003-06-26
PT1305311E (pt) 2008-04-07
BG107604A (bg) 2003-09-30
AP1785A (en) 2007-10-04
YU14603A (sh) 2006-05-25
NO20030530D0 (no) 2003-02-03
CN1455778A (zh) 2003-11-12
NZ524030A (en) 2004-07-30
BR0112982A (pt) 2003-08-26
WO2002012232A1 (en) 2002-02-14
EP1305311B1 (en) 2008-01-16
OA12354A (en) 2004-03-19
DZ3418A1 (fr) 2002-02-14
HRP20030068A2 (en) 2005-02-28
CZ2003313A3 (cs) 2004-02-18
ATE384059T1 (de) 2008-02-15
HUP0300778A3 (en) 2005-04-28
CY1107252T1 (el) 2012-11-21
EA005408B1 (ru) 2005-02-24
KR100755174B1 (ko) 2007-09-03
IL154275A0 (en) 2003-09-17
ZA200300961B (en) 2004-04-01
US20040014790A1 (en) 2004-01-22
DE60132461T2 (de) 2008-12-24
ECSP034467A (es) 2003-03-31
UA76720C2 (uk) 2006-09-15
DE60132461D1 (de) 2008-03-06
HK1057358A1 (en) 2004-04-02
EP1305311A1 (en) 2003-05-02
JP2004505970A (ja) 2004-02-26
AP2003002736A0 (en) 2003-03-31
MA25832A1 (fr) 2003-07-01
NO324596B1 (no) 2007-11-26
CA2417827A1 (en) 2002-02-14
HUP0300778A2 (hu) 2003-11-28
SK1462003A3 (en) 2004-06-08
KR20030022355A (ko) 2003-03-15
IL154275A (en) 2009-02-11
NO20030530L (no) 2003-02-03
ES2296772T3 (es) 2008-05-01
DK1305311T3 (da) 2008-05-19
SI1305311T1 (sl) 2008-04-30

Similar Documents

Publication Publication Date Title
EP1305312B1 (en) Tartrate salts of thiazolidinedione derivative
MXPA03001085A (es) Farmaceutico novedoso.
NO324020B1 (no) Hydrokloridsalt av 5-[4-[2-(N-metyl-N (2-pyridyl)amino)etoksy]benzyl]tiazolidin-2,4-dion, farmasoytisk sammensetning som innbefatter dette samt fremgangsmate for fremstilling og anvendelse derav
MXPA03001086A (es) Compuesto farmaceutico novedoso.
EP1305310B1 (en) Tartrate salts of thiazolidinedione derivative
US20040102485A1 (en) Tartrate salt of thiazolidinedione derivative
MXPA03002867A (es) Derivado de tiazolidinodiona y su uso como antidiabetico.
AU2001292034A1 (en) A thiazolidinedione derivative and its use as antidiabetic

Legal Events

Date Code Title Description
FG Grant or registration